Santhera Pharmaceuticals Holding AG (0QN1.L) LSE
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 163.98M |
| Enterprise Value | 239.31M |
| P/E Ratio | -6.19 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 2.13 |
| Price/Book Ratio | -32.83 |
| Enterprise/Revenue | 2.12 |
| Enterprise/EBITDA | -64.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.31 |
| Operating Margin | -0.09 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | 3.55 |
Income Statement
| Revenue | 77.19M |
| Revenue/Share | 7.07 |
| Gross Profit | 14.47M |
| EBITDA | -32.13M |
| Net Income | -49.24M |
| Diluted EPS | -3.78 |
Balance Sheet
| Total Cash | 41.77M |
| Total Cash/Share | 2.91 |
| Total Debt | 41.28M |
| Total Debt/Equity | -6.69 |
| Current Ratio | 1.73 |
| Book Value Per Share | -0.43 |
Price History
| 52-Week Change | 43.23 |
| 52-Week High | 18.56 |
| 52-Week Low | 6.15 |
| Moving Average 50 Days | 9.91 |
| Moving Average 200 Days | 8.98 |
Statistics
| Average Volume | 1,302 |
| Shares Outstanding | 15.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 03, 2023 |
AD
